Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Haak (Rochester, United States of America), E. Kostallari (Rochester, United States of America), D. Sicard (Rochester, United States of America), G. Ligresti (Rochester, United States of America), K. Choi (Rochester, United States of America), N. Caporarello (Rochester, United States of America), D. Jones (Rochester, United States of America), Q. Tan (Rochester, United States of America), J. Meridew (Rochester, United States of America), A. Diaz Espinosa (Rochester, United States of America), A. Aravamudhan (Rochester, United States of America), J. Maiers (Rochester, United States of America), R. Britt (Rochester, United States of America), A. Roden (Rochester, United States of America), C. Pabelick (Rochester, United States of America), Y. Prakash (Rochester, United States of America), S. Nouraie (Pittsburgh, United States of America), X. Li (Pittsburgh, United States of America), Y. Zhang (Pittsburgh, United States of America), D. Kass (Pittsburgh, United States of America), D. Lagares (Boston, United States of America), A. Tager (Boston, United States of America), X. Varelas (Boston, United States of America), V. Shah (Rochester, United States of America), D. Tschumperlin (Rochester, United States of America). Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. 2113

Member's Comments

No comment yet.

Related content which might interest you: Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Acupuncture regulates macrophage polarization in COPD mice model by activating dopamine D2 receptor. Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Vasopressin is involved in endothelin receptor antagonist-induced fluid retention in rat. Differential effect of selective ETA and dual ETA/ETB receptor antagonists Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 The endocannabinoids anandamide and 2-arachidonyl-glycerol (2-AG) induce pulmonary hypertension (PH) in a CB1 receptor independent manner - role of COX-2 and EP1 receptor activation Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 Blockage of serotonin receptors and transporter reduces bleomycin lung fibrosis in mice Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005 The expression of muscarinic receptors is involved in the p42/44ERK and NF-kB activation of human lung fibroblasts from COPD subjects Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice Source: Eur Respir J 2008; 32: 426-436 Year: 2008 Reduction in serotonin signaling via TPH1 inhibition attenuates the progression of PAH in mice with genetic ablation of endothelial BMPR-II Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Ligand independent activation of the glucocorticoid receptor by long acting β2 agonists Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Inhibition of cough reflex by D2 receptor agonism with Viozan™ (AR-C68397AA) Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001 Hypoxia-mediated alterations in adenosine receptor expression in rat lung Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Evaluation of a selective 5-hydroxytryptamine 2B receptor antagonist designed to alter the fibrotic process Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice Source: Eur Respir J 2004; 24: Suppl. 48, 334s Year: 2004 Enhanced expression of nicotinic alpha-1 acetylcholine receptor in lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Lynx1 modulates a7 nicotinic receptor activity by inhibition of Src phosphorylation in airway epithelium: A new way to target smoking-induced lung disease Source: Annual Congress 2010 - Epithelial cell biology Year: 2010